AU4365399A - 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical substances containing the same, method for the production and use thereof in photodynamic therapyand mri diagnosis - Google Patents

3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical substances containing the same, method for the production and use thereof in photodynamic therapyand mri diagnosis

Info

Publication number
AU4365399A
AU4365399A AU43653/99A AU4365399A AU4365399A AU 4365399 A AU4365399 A AU 4365399A AU 43653/99 A AU43653/99 A AU 43653/99A AU 4365399 A AU4365399 A AU 4365399A AU 4365399 A AU4365399 A AU 4365399A
Authority
AU
Australia
Prior art keywords
therapyand
photodynamic
production
same
substances containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43653/99A
Other languages
English (en)
Inventor
Wolfgang Ebert
Thomas Frenzel
Ulrich Niedballa
Johannes Dr. Platzek
Bernd Dr. Raduchel
Hanns-Joachim Weinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU4365399A publication Critical patent/AU4365399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU43653/99A 1998-06-02 1999-05-25 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical substances containing the same, method for the production and use thereof in photodynamic therapyand mri diagnosis Abandoned AU4365399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1998125512 DE19825512A1 (de) 1998-06-02 1998-06-02 3-,8-subsituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik
DE19825512 1998-06-02
PCT/EP1999/003514 WO1999062512A1 (de) 1998-06-02 1999-05-25 3-, 8-substituierte deuteroporphyrinderivate, diese enthaltende pharmazeutische mittel, verfahren zu ihrer herstellung und ihre verwendung in der photodynamischen therapie und mri-diagnostik

Publications (1)

Publication Number Publication Date
AU4365399A true AU4365399A (en) 1999-12-20

Family

ID=7870254

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43653/99A Abandoned AU4365399A (en) 1998-06-02 1999-05-25 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical substances containing the same, method for the production and use thereof in photodynamic therapyand mri diagnosis

Country Status (3)

Country Link
AU (1) AU4365399A (de)
DE (1) DE19825512A1 (de)
WO (1) WO1999062512A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482943B1 (en) 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
EP1148057A4 (de) * 1999-11-30 2002-05-29 Photochemical Co Ltd Nitroimidazol unterstützender porphyrin komplex
US6906050B2 (en) 2001-05-31 2005-06-14 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis
DE10240343A1 (de) * 2002-08-27 2004-03-11 Schering Ag Peroxynitrit-Umlagerungskatalysatoren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4232925A1 (de) * 1992-09-28 1994-03-31 Diagnostikforschung Inst 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
WO1999062512A1 (de) 1999-12-09
WO1999062512A9 (de) 2000-03-23
DE19825512A1 (de) 1999-12-09

Similar Documents

Publication Publication Date Title
HRP950217B1 (en) Novel erythromycin derivatives, method for preparing the same and use thereof as drugs
HUP0103111A3 (en) Epothilone derivatives, process for their preparation and their use
HU9603038D0 (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
HUP9901478A3 (en) Carboline derivatives, their use, production thereof and medicaments containing the same
HUP0201711A3 (en) N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them
HUP0105478A3 (en) 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
HUP0001115A3 (en) Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same
HUP9800138A3 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use
AU2002251546A1 (en) Pyrazolo[1,5-A]pyridines and medicines containing the same
HUP9902576A3 (en) Novel erythromycin derivatives, method for preparing them, and use thereof as drugs
HUP0003748A3 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives, process for their preparation their use and pharmaceutical compositions containing the same
HUP0004020A3 (en) Tricyclic triazolobenzazepine derivatives, process for producing the same, and their use as antiallergic agent
EE03830B1 (et) 1H-pürido[3,4-b]indool-4-karboksamiidi derivaadid, nende valmistamismeetodid ja kasutamine raviks
HUP0104033A3 (en) 1-benzoyl-tetrahydropyridazine derivatives, process for their preparation, their use and medicaments containing the compounds
IL138442A0 (en) HYPNOTIC β-CARBOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINAL PRODUCTS
AU4365399A (en) 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical substances containing the same, method for the production and use thereof in photodynamic therapyand mri diagnosis
AU5158599A (en) Photochromic compounds, process for their preparation and their use in polymericmaterials
AU4787799A (en) Method, apparatus and their use in tomographic imaging
HUP0101415A3 (en) 3,7-diazabicyclo [3.3.1]-nonane-carboxylic acid salts, pharmaceutical preparation containing thereof, methods for their preparation and their use
HUP9903424A3 (en) Novel erythromycin derivatives,method for preparing same and use thereof as drugs
GR3035834T3 (en) Benzoxazindione derivatives, process for their preparation and their use
IL130420A (en) Erythromycin derivatives, method for preparing them and their use as medicine
HUP0203045A3 (en) 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use
ATE292114T1 (de) Arylalkanoylderivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zubereitungen
AU3155497A (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase